Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study.


Abstract

Bedtime VLD CBP treatment improved core FM symptoms.

Nights with CAP(A2+A3(Norm)) ≤ 33% may provide a biomarker for assessing treatment effects on nonrestorative sleep and associated fatigue and mood symptoms in persons with FM.


Full Text


Subjects


Similar articles

Authors


Publication date

2011-12-02


Journal

The Journal of rheumatology
J Rheumatol (0315-162X)

Journal topics


Language

Eng.


Copyright

The Journal of rheumatology

Sleep Disorders Clinics, Centre for Sleep and Chronobiology, University of Toronto, Toronto, Ontario, Canada. h.moldofsky [at] utoronto.ca


Release reference

J Rheumatol. 2011 Dec;38(12):2653-63



Related books


Español | English

© Galenicom 1999-2013